logo

For the Inventor, By the Inventor

Watertown, MA, United States of America

Envivo Pharmaceuticals, Inc.


USPTO Granted Patents = 13

% Expired Patents = 100.0



Forward Citations = 76

Loading Chart...
Loading Chart...

17 inventors (with patents filed for the assignee):

goldMedal Richard Chesworth (12 out of 107 patents)

silverMedal Gideon Shapiro (12 out of 75 patents)

bronzeMedal Amy Ripka (5 out of 28 patents)

4.  Gerhard Koenig (2 out of 6 patents)

5.  Yves Andre Chantigny (1 out of 7 patents)

6.  Patricia Oliver-Shaffer (1 out of 9 patents)

7.  Muneki Kishida (1 out of 12 patents)

8.  Takayuki Ishige (1 out of 5 patents)

9.  Patrick Beaulieu (1 out of 4 patents)

10.  Silvana Leit (1 out of 11 patents)

11.  John Mancuso (1 out of 3 patents)

12.  Pierre Tessier (1 out of 6 patents)

13.  David Smil (1 out of 5 patents)

14.  Robert Déziel (1 out of 3 patents)

15.  Christopher J Cummings (1 out of 2 patents)


13 patents:

1. 8710227 - Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate (2014-04-29),
2. 8664249 - Tetrasubstituted benzenes (2014-03-04),
3. 8642638 - Treatment of cognitive disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof (2014-02-04),
4. 8569354 - Treatment of cognitive disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof (2013-10-29),
5. 8481534 - 5- and 6-membered heterocyclic compounds (2013-07-09),
6. 8481532 - PDE-10 inhibitors (2013-07-09),
7. 8466148 - 1,2-disubstituted heterocyclic compounds (2013-06-18),
8. 8399452 - Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors (2013-03-19),
9. 8367863 - Tetrasubstituted benzenes (2013-02-05),
10. 8343973 - Phenoxymethyl heterocyclic compounds (2013-01-01),
11. 8217064 - Tetrasubstituted benzenes (2012-07-10),
12. 8071595 - 1,2-disubstituted heterocyclic compounds (2011-12-06),
13. 7705017 - Compounds for treatment of neurodegenerative diseases (2010-04-27),
Company Overview
Envivo Pharmaceuticals, Inc. is a biopharmaceutical company based in Watertown, MA, focused on developing innovative therapies for central nervous system disorders. The company specializes in advancing treatments that target neurological conditions, leveraging proprietary technologies to enhance drug delivery and efficacy. Envivo's research emphasizes the importance of addressing unmet medical needs in the field of neuroscience, aiming to improve the quality of life for patients through its novel therapeutic approaches.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

13 Patents

#32 in Watertown, MA

#1,441 in Massachusetts

#23,815 in US

#44,988 in the World

Watertown, MA (US)
Watertown, MA, United States of America

Envivo Pharmaceuticals, Inc.

Forward Citations = 76

17 inventors:

goldMedal Richard Chesworth (12 out of 107 patents)

silverMedal Gideon Shapiro (12 out of 75 patents)

bronzeMedal Amy Ripka (5 out of 28 patents)

4.  Gerhard Koenig (2 out of 6 patents)

5.  Yves Andre Chantigny (1 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Envivo Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/envivo-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…